RecruitingPhase 2NCT06656351
B-FREE Chronic Babesiosis Study
Studying Babesiosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- 60 Degrees Pharmaceuticals LLC
- Intervention
- Tafenoquine 100mg(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2027
Study locations (1)
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06656351 on ClinicalTrials.govOther trials for Babesiosis
Additional recruiting or active studies for the same condition.